	Development of an exploratory prediction model for preoperative CK19 expression in esophageal cancer driven by radiomics and machine learning. PLoS One Yang J, Wang S, Chen X, Liu L, Li Y. PMID: 42224263 [PubMed - indexed for MEDLINE]
	Lymph Node Dissection and Postoperative Complications After Lung Cancer Resection. JAMA Netw Open Madeka I, Noueihed K, Woodroof J, Mack S, Rshaidat H, Whitehorn GL, Alaparthi S, Koeneman SH, Grenda TR, Evans NR 3rd, Okusanya OT. PMID: 42223938 [PubMed - indexed for MEDLINE]
	Invasive Fibromatosis Adjacent to the Twelfth Thoracic Vertebra and Involving the Oesophagus. J Coll Physicians Surg Pak Qi Q, Xie W, Song M. PMID: 42219849 [PubMed - indexed for MEDLINE]
	Transposable elements in human cancer: Regulation, activation, and genomic consequences. Adv Genet Diaz-Portal L, Sotelo-Fonseca JE, Rodriguez-Martin B. PMID: 42219646 [PubMed - indexed for MEDLINE]
	Papillary thyroid carcinoma with coexisting venous hemangioma mimicking locally invasive disease: A case report. J Int Med Res Lim JW, Kim HS, Kim YH, Jung KC, Kim JH, Seok J. PMID: 42219240 [PubMed - indexed for MEDLINE]
	A logNII-based model for predicting pathological complete response following neoadjuvant therapy in esophageal squamous cell carcinoma: a retrospective single-center study. World J Surg Oncol Zhang M, Huang J, Wang C, Yang B, Lu T. PMID: 42218485 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Prognostic Value of Circulating Exosomal DNA in Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study. Ann Surg Oncol Nakai T, Kitahata Y, Hiraki H, Nakamura Y, Motobayashi H, Takemoto N, Hyo T, Sato M, Ojima T, Hayata K, Goda T, Kitadani J, Tominaga S, Hayami S, Miyamoto A, Yamaue H, Iwaya T, Nishizuka S, Kawai M. PMID: 42218348 [PubMed - as supplied by publisher]
	Real-world outcomes of FLOT versus Chemoradiotherapy for Esophageal, Type I and II Junctional Tumors: A Bi-Center International Study. Dis Esophagus Alhayo S, Seabourne E, Hall L, Shepherdson M, Edwards S, Stranz C, Prasad S, Trochsler M, Fackrell D, Whiting JL, Griffiths EA, Kanhere H. PMID: 42213868 [PubMed - indexed for MEDLINE]
	Fusobacterium nucleatum in cancer: Interactions with microbiota, tumour colonisation and cancer progression. Clin Transl Med Zhao F, An R, Yu S, Ma Y, Liu W, Sheng C, Xie X, Zhang J. PMID: 42212696 [PubMed - indexed for MEDLINE]
	Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study. Front Oncol Ren HJ, Ren QL, Zhang ZJ, Lei JJ, Xu N. PMID: 42211496 [PubMed]
	LRF-CNN: An explainable lightweight receptive field-based CNN for colorectal cancer histopathological image classification. iScience Yuan L, Li C, Zhang J, Sun H, Rahaman M, Grzegorzek M, Li X. PMID: 42211130 [PubMed]
	The effectiveness of intraoperative indocyanine green fluorescence imaging in preventing anastomotic leakage after minimally invasive esophagectomy for esophageal cancer: a systematic review and meta-analysis. Front Med (Lausanne) Li YH, Qiu JH, Zhang Z, Miao TR, Li YM, Tian H. PMID: 42210944 [PubMed]
	Revisiting Thoracic Duct Resection in Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis and Immunologic Insight Into Recurrence Risk. Thorac Cancer Zhang X, Liu XY, Lv YJ, Li SN, Ao Y, Zhong LQ, Hu Y. PMID: 42206574 [PubMed - indexed for MEDLINE]
	Induction immunochemotherapy followed by concurrent chemoradiotherapy improves survival in unresectable esophageal cancer: a systematic review, meta-analysis, and network meta-analysis. Front Immunol Fan X, Liu X, Mi S, Yang Y, Li C, Zhang J, Hu P. PMID: 42206035 [PubMed - indexed for MEDLINE]
	A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial. ESMO Gastrointest Oncol Okemoto D, Kotani D, Nakamura M, Sato K, Kubo Y, Kadota T, Mishima S, Sakashita S, Hashimoto T, Bando H, Wakabayashi M, Rabinowitz M, Liu MC, Jurdi A, Yamaguchi T, Nishikawa H, Shitara K, Yano T, Kojima T, Fujita T. PMID: 42205796 [PubMed]
	Identification of serum 5'tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer. Sci Rep Zhang L, Zi B, Hong J, Chen Y, Ju S, Jing R, Cui M, Cheng C. PMID: 42204280 [PubMed - as supplied by publisher]
	First-In-Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck. Cancer Sci Matsubara N, Saijo K, Shimizu Y, Okano S, Nakano K, Nishio N, Otsuka T, Kuno H, Miura T, Kubota T, Ikezawa H, Umetsu Y, Ito K, Apfel A, Ye Y, Honma Y. PMID: 42203677 [PubMed - as supplied by publisher]
	Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study. Anticancer Res Lin CY, Lin YS, Fang HY, Wang CC, Liang JA, Li CC, Chien CR. PMID: 42203356 [PubMed - indexed for MEDLINE]
	Value-based pricing of tislelizumab plus chemotherapy versus chemotherapy alone for advanced oesophageal squamous cell carcinoma: a Markov modelling study from the US payer perspective. BMJ Open Abdeen AA, Ayer T, Lim F, Shue S, Hur C. PMID: 42203284 [PubMed - indexed for MEDLINE]
	Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer. N Engl J Med Shitara K, Elimova E, Liu T, Tabernero J, Lee KW, Schenker M, Tebbutt NC, Ajani J, Salimin N, Ku G, Gwang Kim J, Ales Diaz I, Zhang J, Pietrantonio F, Bai LY, Le Sourd S, Zhao J, Hierro C, Kiberu A, Van Herpe F, Bao Y, Zhang H, Yang L, Li V, Gartner EM, Chen Y, Grim J, Rha SY, Shen L, HERIZON-GEA-01 Investigators. PMID: 42202319 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 38926

Page 1 of 1947



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy